(Reuters) - Danaher Corp on Monday agreed to buy protein consumables manufacturer Abcam Plc in a $5.7 billion all-cash deal including debt, as the medical tools supplier looks to expand its portfolio ...

As British research supplies and tools provider Abcam moves toward a potential multibillion-dollar sale, one of the company's founders and major shareholders is pushing back. Dr. Jonathan Milner, an ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -Abcam shareholders on Monday approved the proposal from Danaher Corp to acquire all outstanding shares of the company ...

Abcam (LON:ABC) has had a rough month with its share price down 11%. It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative sentiment.

Abcam PLC (NASDAQ:ABCM) is a $3.8 billion market cap biotechnology stock on the Nasdaq Global Select Market. It is moving its primary listing from Londons AIM (previously known as the Alternative ...

Abcam to license in VHH phage library (1) from Twist, complementing in-house recombinant antibody capabilities Abcam to develop and commercialize antibodies for diagnostic and research use, with Twist ...

Sept 14 (Reuters) - Abcam Plc founder Jonathan Milner on Thursday said he would vote against medical tools supplier Danaher's (DHR.N), opens new tab proposed $5.7 billion acquisition of the company, ...

Danaher Corp. said it will acquire Abcam Plc in a deal worth $5.7 billion, beating out rivals in a race to acquire the UK-based maker of supplies for the life-sciences industry whose technologies are ...

LAUSANNE, Switzerland & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and abcam (NASDAQ: ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. In 2022, Cambridge biotech Abcam decided that it preferred a US listing to a UK one. Now after a short stint on ...

CAMBRIDGE, England & WALTHAM, Mass.--(BUSINESS WIRE)-- Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today filed and mailed a ...